ArticlePediatric nephrology (Berlin, Germany)2026
The relationship between serum copeptin levels, peritoneal transport parameters, and bioimpedance markers in pediatric patients undergoing peritoneal dialysis.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe pathophysiology of hypervolemia in chronic kidney disease involves multiple mechanisms, with arginine vasopressin (AVP) playing a key role. Copeptin, a molecule located at the C-terminus of AVP, is often used as a substitute for AVP in clinical studies. In this study, we aimed to determine copeptin levels in pediatric patients with kidney failure treated by peritoneal dialysis (PD) and evaluate any possible correlation between bioimpedance parameters (BIA) and peritoneal transport parameters obtained from the peritoneal equalization test (PET).
methodsThe study included 37 patients undergoing PD as the patient group and 37 healthy children of the same gender and similar age as the control group. Patients' serum and peritoneal dialysis fluid copeptin levels and PET and BIA parameters were evaluated simultaneously, and possible relationships between them were examined.
resultsSerum copeptin levels in the patient group were found to be significantly higher than those in the control group (7.31 ng/ml vs. 2.55 ng/ml, p < 0.001). A negative correlation was observed between serum copeptin levels and age distribution in the control group. No relationship was found between serum copeptin levels and age or gender in the patient group. Furthermore, no significant correlation was found between serum copeptin levels and clearance values as well as transport parameters obtained by PET parameters and BIA parameters.
conclusionsSerum copeptin levels are higher in patients on PD compared to the control group. However, no significant relationship is found between serum copeptin level and BIA or PET parameters. Further studies are needed to understand more about this subject.
Indexed as
Identifiers
41074990What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.